53 results
POS AM
5ze5jn
3 Mar 22
Prospectus update (post-effective amendment)
8:29am
8-K
EX-99.1
40yervjz ugm
3 Mar 22
Passage Bio Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
7:15am
POSASR
jgsfl anx
3 Mar 22
Automatic shelf registration (post-effective amendment)
7:00am
8-K
897u15n8 un
10 Jan 22
Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline
8:00am
8-K
EX-99.1
ayj4mp2c95k3myad st
10 Jan 22
Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline
8:00am